1. From triazines and triazenes to temozolomide;Stevens;Eur. J. Cancer,1993
2. Alteration of DNA by 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (NSC-407347);Mizuno;Biochem. Pharmacol.,1976
3. Antitumor Imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5, 1-d]-1,2,3,5-tetrazin-4(3H)-one, a novel broad-spectrum antitumor agent;Stevens;J. Medicin. Chem.,1984
4. Experimental antitumor activity against murine tumor model systems of 8-carbamoyl-3-(2-chloroethyl)imidazo[5, 1-d]-1,2,3,5-tetrazin-4(3H)-one (mitozolomide), a novel broad-spectrum agent;Hickman;Cancer Res.,1985
5. Phase I clinical trial of mitozolomide (CCRG 81010; M&B 39565; NSC 353451);Newlands;Cancer Treat. Rep.,1985